• 1. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 2. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 3. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate (CAS No. 367500-93-4): A Key Intermediate in Modern Pharmaceutical Synthesis

Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate (CAS No. 367500-93-4) is a highly significant compound in the realm of pharmaceutical chemistry, serving as a crucial intermediate in the synthesis of various bioactive molecules. Its unique structural framework, combining an imidazole ring with a pyridine moiety and a fluorine substituent, makes it a versatile building block for drug development. This introduction delves into the compound's chemical properties, synthetic pathways, and its growing prominence in contemporary medicinal chemistry research.

The molecular structure of Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate encompasses a pyridine ring fused with an imidazole ring at the 1 and 2 positions, with a fluorine atom attached to the imidazole ring at the 6-position. The ester functionality at the 2-position of the pyridine ring enhances its reactivity, making it an ideal candidate for further functionalization. This structural configuration not only imparts stability to the molecule but also allows for diverse chemical modifications, which are essential for tailoring its pharmacological properties.

In recent years, there has been a surge in interest regarding heterocyclic compounds due to their wide-ranging biological activities. Among these, imidazopyridines have emerged as particularly promising scaffolds for developing novel therapeutic agents. The fluorine atom in Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate plays a pivotal role in modulating the compound's bioavailability and binding affinity to biological targets. Fluorinated aromatic compounds are well-known for their ability to enhance metabolic stability and binding interactions within biological systems, making them invaluable in drug design.

The synthesis of Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate typically involves multi-step organic reactions that require precise control over reaction conditions. One common synthetic route involves the condensation of appropriately substituted imidazole derivatives with pyridine carboxylic acid esters under acidic or basic catalysis. The introduction of the fluorine atom can be achieved through nucleophilic aromatic substitution or metal-catalyzed cross-coupling reactions. These synthetic methodologies highlight the compound's versatility and its potential for further chemical exploration.

Recent advancements in pharmaceutical research have underscored the importance of Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate as a precursor in developing novel therapeutics. For instance, studies have demonstrated its utility in generating small molecule inhibitors targeting various kinases and enzymes implicated in cancer and inflammatory diseases. The fluorine substituent's electronic effects can fine-tune the compound's interactions with biological targets, leading to enhanced potency and selectivity. Such findings have spurred further investigation into its derivatives as potential drug candidates.

The pharmacological potential of derivatives of Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate has been explored in several preclinical studies. Researchers have synthesized and evaluated various analogs for their ability to modulate signaling pathways associated with diseases such as cancer and neurodegeneration. The ester group in the molecule provides a handle for further derivatization, allowing chemists to explore different pharmacophores while retaining the core scaffold's desirable properties. This flexibility has made it a favorite among medicinal chemists seeking to develop innovative treatments.

The growing interest in fluorinated heterocycles has also led to the development of new synthetic strategies that enhance efficiency and scalability. Catalytic methods, particularly those involving transition metals like palladium and copper, have been employed to introduce fluorine atoms with high precision. These advances have not only streamlined the synthesis of Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate but also opened doors for exploring more complex fluorinated derivatives.

In conclusion, Ethyl 6-fluoroimidazo1,2-apyridine-2-carboxylate (CAS No. 367500-93-4) represents a cornerstone in modern pharmaceutical synthesis. Its unique structural features and reactivity make it an indispensable intermediate for developing novel bioactive molecules. As research continues to uncover new therapeutic applications for fluorinated heterocycles, the demand for high-quality intermediates like this compound is expected to rise. The ongoing advancements in synthetic methodologies further solidify its importance in drug discovery efforts worldwide.

• 367900-94-5(6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1260763-32-3(Ethyl 6-bromo-8-fluoroimidazo1,2-apyridine-2-carboxylate)
• 38922-77-9(Ethyl imidazo[1,2-a]pyridine-2-carboxylate)
• 1260843-88-6(8-Fluoro-imidazo1,2-apyridine-2-carboxylic acid ethyl ester-)
• 1313408-99-9(7-fluoro-Imidazo[1,2-a]pyridine-3-carboxylic acid ethyl ester)
• 1260798-14-8(7-Fluoro-imidazo1,2-apyridine-2-carboxylic Acid ethyl ester)
• 1020034-56-3(8-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1359655-87-0(Ethyl 6-fluoroimidazo[1,2-a]pyridine-3-carboxylate)
• 367500-94-5(6-Fluoroimidazo[1,2-a]pyridine-2-carboxylic acid)
• 1019021-85-2(6-Fluoroimidazo[1,2-a]pyridine-3-carboxylic acid)